Van ECK Associates Corp Has $337.79 Million Stake in GE HealthCare Technologies Inc. $GEHC

Van ECK Associates Corp grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,497,827 shares of the company’s stock after purchasing an additional 139,404 shares during the quarter. Van ECK Associates Corp owned about 0.99% of GE HealthCare Technologies worth $337,787,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in GEHC. Vanguard Group Inc. increased its position in GE HealthCare Technologies by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after buying an additional 703,903 shares during the period. Capital Research Global Investors grew its stake in shares of GE HealthCare Technologies by 25.0% in the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after acquiring an additional 4,998,154 shares during the last quarter. Dodge & Cox grew its stake in shares of GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after acquiring an additional 6,982,441 shares during the last quarter. State Street Corp increased its position in GE HealthCare Technologies by 1.9% during the second quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after acquiring an additional 372,755 shares during the period. Finally, Geode Capital Management LLC raised its stake in GE HealthCare Technologies by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock valued at $881,060,000 after purchasing an additional 231,302 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $75.63 on Tuesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The company has a 50-day moving average of $81.66 and a 200-day moving average of $78.62. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77. The company has a market capitalization of $34.47 billion, a price-to-earnings ratio of 16.59, a PEG ratio of 1.63 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. BTIG Research increased their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Jefferies Financial Group upped their price objective on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Wall Street Zen upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their target price for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Finally, Barclays boosted their price target on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research note on Friday, February 6th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.